9th Annual Biomarkers Congress

Drug Design: Wyeth BioPharma

Total Score People Score Events Score
61 51 52
Date Event Presentation Speakers
April 27, 2010 Fragment Based Drug Discovery SPR-Based Screening of Fragment Library: Case Studies Girija Krishnamurthy
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit 4 Building a Clinical Trial Unit in Academic Medical Centers Frank Fan
November 13, 2009 Globalization and standardization: Agreements-Budget-Regulation-Operations. New Presentation Frank Fan
November 2, 2009 Seventh Annual Strategic Resource Management TABLE #10: Controlling Bias in Portfolio Management Robin G. Foldesy
TABLE 8: Pursuing Operational Excellence: Competitive Advantages, New Operating Models, a New Lean Industry, and Learning from Resource Process Development beyond just Clinical James Kirwin
Flexible Resourcing Models for Clinical Development James Kirwin
The Impact of Organizational Culture on Resource and Portfolio Management “Best Practices” Richard J Heaslip
November 2, 2009 Track 3: Fourth Annual Ion Channels as Therapeutic Targets Hits Validation Using Endogenous Ion Channels Expressed on Human CD4+ T Cells Melisa Ho
September 29, 2009 Paediatric Drug Development Pharmacokinetics, dynamics and metabolism in children David McIntosh
September 24, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual clinical biomarkers Translational Medicine’s Role in Target Validation and Patient Selection in Oncology Drug Development Giora Feuerstein
September 24, 2009 Track 2: Implementing Personalized Medicine : Inaugural Targeted Therapy Translational Medicine’s Role in Target Validation and Patient Selection in Oncology Drug Development Giora Feuerstein
August 3, 2009 The Next Wave of Antibody Therapeutics Targeting B-Cell Lymphomas with Inotuzumab Ozogamicin (CMC-544), an Anti-CD22 Immunoconjugate Erik R. Vandendries
June 9, 2009 RNAi for Target Identification and Validation High-Throughput RNAi Genetic Screens for Drug Discovery and Development Attila A. Seyhan
June 4, 2009 Structure-Based Drug Design SPR-Based Screening of Fragment Library and Follow-up of Hits Girija Krishnamurthy
May 11, 2009 Patient Recruitment in Clinical Trials Regulatory Challenges and Expectations in Latin America and Asia Pacific to Effective Clinical Trial Development Jerry Stewart
April 21, 2009 3rd Annual Clinical Trials in Emerging Economies Keynote Case Study – China: Essential regulatory authority and ethics committee information Ling Su
April 6, 2009 Inaugural THE IMPACT OF OUTSOURCING CHEMISTRY AT THE PROJECT LEVEL Using the Same Outsourcing Partner for Discovery and Process Chemistry: Opportunities and Challenges Michael Kolb
Panel Session: A Day in the Life of an Outsourcing Project Manager Michael Kolb
March 17, 2009 Bio Medical Asia 2009 Development of simplified approaches to downstream process development, characterization and manufacturing Ranga , Godavarti
March 11, 2009 Electronic Data in Clinical Trials Integration of EDC with other eClinical Systems Ed Kellar
Panel with Speakers - The Sponsors’ Perspective: Working With EDC Ed Kellar
March 3, 2009 2nd annual Competitive Intelligence in Pharma Roundtable sessions : Building effective internal CI structure Craig McHenry
Brain-like intelligence for CI – could it happen? Craig McHenry
February 24, 2009 Lifecycle Management of the eCTD eCTD lifecycle management in the centralised procedure Joerg Schnitzler
February 24, 2009 11th National Conference on Managing Legal Risks in Structuring & Conducting Clinical Trials Co-Chairs’ Opening Remarks Charlene A. Gallagher
Preventing Charges of Off-Label Promotion When Disseminating Clinical Trial Materials Charlene A. Gallagher
February 9, 2009 Immunogenicity for Biologics 2009 Anti-drug antibody (ADA) assay validation: Industry survey results and data analysis Boris Gorovits
February 4, 2009 Adaptive Designs in Clinical Drug Development OPENING KEYNOTE – PROGRESS IN IMPLEMENTATION? Michael Krams
January 27, 2009 6th Annual Clinical Trial Performance Metrics Critical success factors for monitoring metrics - an example case in Japan Atsushi Kitamura
January 27, 2009 Forced Degradation Studies Application of forced degradation data to formulation development Philip Jupp
January 26, 2009 7th Annual Partnering with Central Labs Risk Assessment : Improve Operational Success by Developing Vendor Quality Management Plans Marie Ulrich
January 21, 2009 13th Annual Drug Delivery Partnerships TRACK A : Panel Discusion: Large Pharma and Their Tim Saxon
November 26, 2008 4th Annual Audits and Inspections for Clinical Trials and Pharmacovigilance Essential guidance from the legal and regulatory requirements to ensure an inspection proof Pharmacovigilance process Thomas Steinbach,
November 12, 2008 Third Annual Post-Approval Drug Safety Strategies: Best Practices to Mitigate Risks throughout the Product's Life Cycle Optimizing the Allocation of an Organization's Drug Safety Assessment Resources Jill Robinson
Table 2. Outsourcing Post Approval-Drug Safety Jill Robinson
Chairperson’s Opening Remarks and Roundtable Report Outs Jill Robinson
November 12, 2008 11th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements Setting the Stage for Success by Choosing the Right Partner and Conducting Effective Due Diligence William Jacobsen
November 5, 2008 Bridging the Business Development & Alliance Management Interface Building an Effective Business Development/Alliance Management Interface – Wyeth's Experience Varavani Dwarki
November 3, 2008 ASAP-CHI Bio-Pharma Alliance Summit Building an Effective Business Development/Alliance Management Interface – Wyeth's Experience Varavani Dwarki
October 23, 2008 Adaptive Clinical Trial Designs Discussant Michael Krams
Discussant Michael Krams
October 8, 2008 Accelerating Proof Of Concept “Learn and Confirm” - Implementing Early Proof-of-Concept at Wyeth Charles Gombar
September 17, 2008 BACULOVIRUS TECHNOLOGY Baculovirus Protein Expression Strategies for Drug Discovery Kerry Kelleher
March 30, 2008 Nuclear Receptors: Steroid Sisters Steroid Receptor Signaling and Dynamics Boris Cheskis
Drug Development Leonard P. Freedman
March 30, 2008 Nuclear Receptors: Orphan Brothers Steroid Receptor Signaling and Dynamics Boris Cheskis
Drug Development Leonard P. Freedman
March 29, 2008 Computer-Aided Drug Design Ligand-Based Drug Design Diane Joseph-McCarthy
December 10, 2007 Regulatory Audits & Inspections Auditing Techniques To Determine Compliance Risks John Shaeffer
December 4, 2007 7th World Drug Discovery & Development Summit 2007 KEYNOTE: ACADEMIC AND INDUSTRY COLLABORATION - THE FUTURE FOR DISCOVERY AND DEVELOPMENT Orest Hurko
November 28, 2007 Second Annual Portfolio Management: Creating a Portfolio for Optimal Productivity Nov (28-29) BRIDGING PLENARY SESSION : The Critical Role of Program Leaders in Ensuring Optimum Portfolio and Resource Management (16:00-16:45) Richard J Heaslip
INTERACTIVE PANEL DISCUSSION: How Can We Translate These Lessons Learned from other industries into Helpful Tools for Pharma? (11:05-11:50) Richard J Heaslip
November 27, 2007 Fifth Annual Strategic Resource Management: The Key to Increasing R&D Productivity Nov (27-28) PRE-CONFERENCE WORKSHOP Part 2: Laboratory Asset Management -Maximizing Your Investment in Laboratory Equipment (10:30-11:30) Michael Pirone
PRE-CONFERENCE WORKSHOP Part 1: Laboratory Asset Management -Maximizing Your Investment in Laboratory Equipment (08:30-10:00) Michael Pirone
PRE-CONFERENCE WORKSHOP: Laboratory Asset Management -Maximizing Your Investment in Laboratory Equipment (08:30-11:30) Michael Pirone
Implementing the Learn and Confirm Development Paradigm at Wyeth (15:15-16:00) Matt Bell
Meeting the Demands of Today’s R&D Environment (13:15-14:00) Robin G. Foldesy
INTERACTIVE PANEL DISCUSSION: Creating a Process to Successfully Transfer Internal and External Resources among Projects (11:45-12:30) Robin G. Foldesy
BRIDGING PLENARY SESSION: The Critical Role of Program Leaders in Ensuring Optimum Portfolio and Resource Management (16:00-16:45) Richard J Heaslip
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) CLINICAL DEVELOPMENT AND OPERATIONS (09:10-14:45) Dianne C. Kikta
CLINICAL DEVELOPMENT AND OPERATIONS: INTERACTIVE PANEL:Outsourcing Globally and Executing International Trials in India (14:00-14:45) Dianne C. Kikta
CLINICAL DEVELOPMENT AND OPERATIONS: An Innovative Approach to Establishing a Clinical Research Presence in India: The Wyeth Experience (09:50-10:30) Dianne C. Kikta
November 7, 2007 Bridging the Business Development/Alliance Management Interface Nov(7-8) Aligning Business Development, Alliance Management, Corporate Venture Investment and Project Management to Ensure Effective Alliances (9:40-10:30) Varavani Dwarki
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 13: (Part One) Development of Novel Drug Delivery Systems (Part Two) Combinatorial Chemistry & High Throughput Screening (09:00-12:00) Xiaoke Yang
Session 13: (Part One): Binding Characterization of the IL-13 Signaling Complex and Development of a Ternary TR-FRET Assay (10:20-10:40) Xiaoke Yang
October 25, 2007 Pain Therapeutics Summit 2007 Workshop concludes / Conference registration begins Michele Hummel
October 17, 2007 Second Annual Ion Channels: An Emerging Target for Therapeutic Development Oct (17-18) TARGETING NEUROPSYCHIATRIC DISORDERS (15:45-18:20) John Dunlop
TARGETING NEUROPSYCHIATRIC DISORDERS: Exploring Positive Allosteric Modulators of the Alpha7 Nicotinic Receptor (15:45-16:15) John Dunlop
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) DISCOVERY CHEMISTRY (08:35-12:55) Matthew R. Yudt
DISCOVERY CHEMISTRY: Discovery of Progesterone Receptor Modulators with a Unique Mechanism of Action (10:55-11:25) Matthew R. Yudt
October 16, 2007 Second Annual Putting Theory into Practice: Adaptive Clinical Trial Designs (Oct 16-17 SESSION I: LAYING THE GROUND WORK FOR EARLY DECISION MAKING (13:45 - 19:00) Michelle J. Ballard
SESSION I: How Wyeth is Transforming R&D - The Learn and Confirm Model of Clinical Development (14:30 - 15:00) Michelle J. Ballard
CASE STUDIES (11:15-14:45) Evan Tzanis, Micheline Marshall
CASE STUDY: Phase II Opioid Induced Constipation Dosing Study (14:45-15:15) Evan Tzanis
CASE STUDY: Planning and Supplying Drug for Clinical Studies Using Flexible Designs(15:15-15:45) Micheline Marshall
October 16, 2007 Inaugural Kinbase Inhibitors: Moving Forward into Clinical Studies Oct (16-17) New Therapeutics Scopes (10:35-12:40) Jean-Baptiste Telliez
New Therapeutics Scopes: The MK2/MK3 Pathway in Inflammation and Beyond (10:40-11:10) Jean-Baptiste Telliez
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) In vitro RNAi Screening Strategies (08:30-10:40) Brian Bates
In vitro RNAi Screening Strategies: Probing Mammalian Neuritogenesis through siRNA Screening (09:40-10:10) Brian Bates
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) BIOIMAGING FOR MONITORING RESPONSE TO THERAPY, DOSE SELECTION, ASSESSING MOLECULAR ACTIVITY AND RECEPTOR OCCUPANCY (08:00-13:30) Alex Valentin
Studying Fracture Healing - The Use of Bioimaging for Recombinant Human Bone Morphogenetic Protein-2 (Rhbmp-2) Studies (08:05-08:35) Alex Valentin
October 2, 2007 IVT 's Lab Week Qualifying a Chamber from Start to Finish to Remain in Compliance | Session 11 Patrick Bell
Conducting the Pre- and Post Qualification Studies | Session 11 Patrick Bell
Interactive Exercise | Session 11 Patrick Bell
Integrate Laboratory Information Management Systems (LIMS) to Optimize Stability Programs Patrick Bell
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: PHARMACOGENETICS: The Role of Pharmacogenomics in Discovery Translational Medicine: From Target Validation to Patient Selection (08:35-09:05) Giora Feuerstein
Third annual Genomic Biomarkers: PHARMACOGENETICS (08:30-11:30) Giora Feuerstein
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.